A novel pretargeting method for measuring antibody internalization in tumor cells

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Antibody internalization is crucial for targeted drug delivery and imaging.
• Quantifying antibody internalization is challenging with conventional methods like acid-wash, which can damage cell membranes.
• Pretargeting strategies offer improved specificity and efficacy in antibody-based therapies.

Purpose of the Study:

• To develop and validate a novel pretargeting method for accurate quantitation of antibody cellular internalization.
• To assess the utility of the developed method as a universal alternative to conventional techniques.
• To determine the cell-surface residence time of a specific antibody conjugate.

Main Methods:

• Conjugating an antibody with a phosphorodiamidate morpholino oligomer (MORF).
• Utilizing a complementary MORF (cMORF) as a radiolabeled effector molecule.
• Comparing radioactivity in cells treated with MORF-antibody (pretargeting group) versus radiolabeled MORF-antibody (direct targeting group).
• Calculating internalized antibody fraction based on the difference in radioactivity accumulation.

Main Results:

• The pretargeting method accurately quantifies antibody internalization.
• The method demonstrated that the internalization of a MORF-conjugated anti-prostate-specific membrane antigen antibody (3C6) in LNCaP cells.
• The average cell-surface residence time for the 3C6 antibody was determined to be 2 hours.
• The developed method avoids damage to the cell membrane, unlike conventional acid-wash methods.

Conclusions:

• The novel pretargeting method provides a reliable and non-damaging approach to quantify antibody cellular internalization.
• This technique is directly applicable to pretargeting applications and serves as a universal alternative to existing methods.
• The findings contribute to advancing antibody-based therapies and diagnostics by enabling precise measurement of antibody uptake.